Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart (Q46237716)

20 December 2017

title

Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart (English)

1 reference

20 December 2017

1 reference

Jutta Meyer-Kirchrath

1

1 reference

20 December 2017

Melanie Martin

2

1 reference

20 December 2017

Christina Schooss

3

1 reference

20 December 2017

Christoph Jacoby

4

1 reference

20 December 2017

Ulrich Flögel

5

1 reference

20 December 2017

Andrea Marzoll

6

1 reference

20 December 2017

Jens W Fischer

7

1 reference

20 December 2017

Jürgen Schrader

8

1 reference

20 December 2017

Karsten Schrör

9

1 reference

20 December 2017

Thomas Hohlfeld

10

1 reference

20 December 2017

publication date

18 November 2008

1 reference

20 December 2017

published in

Cardiovascular Research

1 reference

20 December 2017

volume

81

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

310-318

1 reference

20 December 2017

Cellular signalling mechanisms in adaptation to ischemia-induced myocardial damage

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Expression, function, and regulation of E-type prostaglandin receptors (EP3) in the nonischemic and ischemic pig heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Reduction of infarct size by selective stimulation of prostaglandin EP(3)receptors in the reperfused ischemic pig heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Selective activation of E-type prostanoid(3)-receptors reduces myocardial infarct size. A novel insight into the cardioprotective effects of prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Trophic effects of the cyclooxygenase-2 product prostaglandin E(2) in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Open-loop stochastic control of pharmacokinetic systems: a new method for design of dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Biglycan is required for adaptive remodeling after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Direct comparison of magnetic resonance imaging and conductance microcatheter in the evaluation of left ventricular function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Regulatory interactions between the amino terminus of G-protein betagamma subunits and the catalytic domain of phospholipase Cbeta2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Calcium-calcineurin signaling in the regulation of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Cardiac hypertrophy: the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

The relationship between myocardial extracellular matrix remodeling and ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Connective tissue and the heart. Functional significance and regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

A role for decorin in the remodeling of myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN312

21 January 2018

Identifiers

DOI

10.1093/CVR/CVN312

1 reference

20 December 2017

PubMed ID

19019835

1 reference

20 December 2017